GlassScriptPhysician profile
Cierra Oneal
NPI 1346787231
$3,397.32
in general payments reported to CMS, 2019-2025
32 companies · $874 in 2025
The $874 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $897 · 2023: $705 · 2024: $815 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $675.60 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $450.87 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $401.77 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $203.66 | 2022-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.64 | 2021-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $145.54 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $144.16 | 2022-2025 | |
| Pfizer INC. | $128.04 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $106.85 | 2022-2024 | |
| Dynavax Technologies Corporation | $79.04 | 2022-2025 | Heplisav-B |
| Bayer Healthcare Pharmaceuticals INC. | $78.96 | 2022-2023 | |
| Exact Sciences Corporation | $78.31 | 2023-2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $77.84 | 2023-2025 | Gemtesa |
| Daiichi Sankyo INC. | $76.53 | 2022-2025 | Injectafer |
| Otsuka America Pharmaceutical, INC. | $65.31 | 2024-2025 | Rexulti |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $63.85 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.36 | 2022-2024 | Trintellix |
| Stryker Corporation | $51.39 | 2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.66 | 2022-2025 | Jardiance |
| Zimmer Biomet Holdings, INC. | $40.39 | 2025 | Rosa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.25 | 2022-2023 | |
| Inari Medical, INC. | $31.83 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Corcept Therapeutics | $28.48 | 2024-2025 | Korlym |
| Amgen INC. | $27.26 | 2022 | |
| Inspire Medical Systems, INC. | $23.51 | 2025 | Inspire |
| Edwards Lifesciences Corporation | $22.24 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biogen, INC. | $21.96 | 2024 | Skyclarys |
| Biohaven Pharmaceuticals, INC. | $16.93 | 2021 | |
| Seqirus USA INC | $16.76 | 2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Sanofi-Aventis U.S. LLC | $15.10 | 2025 | |
| Alexion Pharmaceuticals, INC. | $12.62 | 2022 | |
| Organon LLC | $6.61 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cierra Oneal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.